228 related articles for article (PubMed ID: 32338490)
1. Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release.
Ye W; Chen X; Li X; Liu Y; Jia F; Jin Q; Ji J
ACS Appl Mater Interfaces; 2020 May; 12(20):22560-22571. PubMed ID: 32338490
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of telomerase and the enzyme activity-triggered drug release by using a conformation-switchable nanoprobe in cancerous cells.
Shi H; Gao T; Shi L; Chen T; Xiang Y; Li Y; Li G
Sci Rep; 2018 Nov; 8(1):16341. PubMed ID: 30397241
[TBL] [Abstract][Full Text] [Related]
3. Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics.
Kim J; Lee YM; Kang Y; Kim WJ
ACS Nano; 2014 Sep; 8(9):9358-67. PubMed ID: 25184691
[TBL] [Abstract][Full Text] [Related]
4. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
Miao D; Yu Y; Chen Y; Liu Y; Su G
Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
[TBL] [Abstract][Full Text] [Related]
5. A sequentially responsive and structure-transformable nanoparticle with a comprehensively improved 'CAPIR cascade' for enhanced antitumor effect.
Xu C; Sun Y; Yu Y; Hu M; Yang C; Zhang Z
Nanoscale; 2019 Jan; 11(3):1177-1194. PubMed ID: 30601512
[TBL] [Abstract][Full Text] [Related]
6. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
7. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-carboxymethyl xanthan gum capped gold nanoparticles: Microwave synthesis, characterization, and anti-cancer activity.
Alle M; G BR; Kim TH; Park SH; Lee SH; Kim JC
Carbohydr Polym; 2020 Feb; 229():115511. PubMed ID: 31826400
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin encapsulated clicked gold nanoparticle clusters exhibiting tumor-specific disassembly for enhanced tumor localization and computerized tomographic imaging.
Mao W; Kim HS; Son YJ; Kim SR; Yoo HS
J Control Release; 2018 Jan; 269():52-62. PubMed ID: 29113793
[TBL] [Abstract][Full Text] [Related]
11. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
12. Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy.
Yan H; Dong J; Huang X; Du X
ACS Appl Mater Interfaces; 2021 Jun; 13(24):29070-29082. PubMed ID: 34101411
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
Lin W; Zhang X; Qian L; Yao N; Pan Y; Zhang L
Biomacromolecules; 2017 Dec; 18(12):3869-3880. PubMed ID: 29032674
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
15. Facile fabrication of multi-pocket nanoparticles with stepwise size transition for promoting deep penetration and tumor targeting.
Hou X; Zhong D; Li Y; Mao H; Yang J; Zhang H; Luo K; Gong Q; Gu Z
J Nanobiotechnology; 2021 Apr; 19(1):111. PubMed ID: 33874945
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Dynamic Disentangling of Doxorubicin Release from Luminescent Nanogold Carriers by Fluorescence Lifetime Imaging Microscopy (FLIM) under Two-Photon Excitation.
Suarasan S; Craciun AM; Licarete E; Focsan M; Magyari K; Astilean S
ACS Appl Mater Interfaces; 2019 Feb; 11(8):7812-7822. PubMed ID: 30707545
[TBL] [Abstract][Full Text] [Related]
17. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
[TBL] [Abstract][Full Text] [Related]
18. Size-Controllable DNA Origami-Stacked Gold Nanoparticles for Deep Tumor-Penetrating Therapy.
Gu D; Qiao Y; Fu H; Zhao H; Yue X; Wang S; Yin Y; Xi R; Fu X; Zhao X; Meng M
ACS Appl Mater Interfaces; 2022 Aug; 14(33):38048-38055. PubMed ID: 35950900
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
20. Tumor pH-triggered "charge conversion" nanocarriers with on-demand drug release for precise cancer therapy.
Ma BA; Sun CY
J Mater Chem B; 2020 Oct; 8(40):9351-9361. PubMed ID: 32996552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
